These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7662653)
1. A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains. Stevens FJ; Myatt EA; Chang CH; Westholm FA; Eulitz M; Weiss DT; Murphy C; Solomon A; Schiffer M Biochemistry; 1995 Aug; 34(34):10697-702. PubMed ID: 7662653 [No Abstract] [Full Text] [Related]
2. A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding. Khurana R; Souillac PO; Coats AC; Minert L; Ionescu-Zanetti C; Carter SA; Solomon A; Fink AL Amyloid; 2003 Jun; 10(2):97-109. PubMed ID: 12964417 [TBL] [Abstract][Full Text] [Related]
3. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418 [TBL] [Abstract][Full Text] [Related]
4. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain. Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800 [TBL] [Abstract][Full Text] [Related]
5. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI. Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891 [TBL] [Abstract][Full Text] [Related]
6. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins. Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639 [TBL] [Abstract][Full Text] [Related]
7. Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis. Brumshtein B; Esswein SR; Sawaya MR; Rosenberg G; Ly AT; Landau M; Eisenberg DS J Biol Chem; 2018 Dec; 293(51):19659-19671. PubMed ID: 30355736 [TBL] [Abstract][Full Text] [Related]
9. A Substantial Structural Conversion of the Native Monomer Leads to in-Register Parallel Amyloid Fibril Formation in Light-Chain Amyloidosis. Lecoq L; Wiegand T; Rodriguez-Alvarez FJ; Cadalbert R; Herrera GA; Del Pozo-Yauner L; Meier BH; Böckmann A Chembiochem; 2019 Apr; 20(8):1027-1031. PubMed ID: 30565364 [TBL] [Abstract][Full Text] [Related]
10. The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation. Nokwe CN; Hora M; Zacharias M; Yagi H; John C; Reif B; Goto Y; Buchner J J Mol Biol; 2015 Nov; 427(22):3572-3586. PubMed ID: 26408269 [TBL] [Abstract][Full Text] [Related]
11. MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors. Hora M; Sarkar R; Morris V; Xue K; Prade E; Harding E; Buchner J; Reif B PLoS One; 2017; 12(7):e0181799. PubMed ID: 28746363 [TBL] [Abstract][Full Text] [Related]
13. Alternative conformations of amyloidogenic proteins govern their behavior. Kelly JW Curr Opin Struct Biol; 1996 Feb; 6(1):11-7. PubMed ID: 8696966 [TBL] [Abstract][Full Text] [Related]
15. Thermal stability threshold for amyloid formation in light chain amyloidosis. Poshusta TL; Katoh N; Gertz MA; Dispenzieri A; Ramirez-Alvarado M Int J Mol Sci; 2013 Nov; 14(11):22604-17. PubMed ID: 24248061 [TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin light chain amyloid aggregation. Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961 [TBL] [Abstract][Full Text] [Related]
17. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils. Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552 [TBL] [Abstract][Full Text] [Related]
18. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain. Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059 [TBL] [Abstract][Full Text] [Related]
19. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Olsen KE; Sletten K; Westermark P Biochem Biophys Res Commun; 1998 Oct; 251(2):642-7. PubMed ID: 9792827 [TBL] [Abstract][Full Text] [Related]
20. Cryo-EM reveals the steric zipper structure of a light chain-derived amyloid fibril. Schmidt A; Annamalai K; Schmidt M; Grigorieff N; Fändrich M Proc Natl Acad Sci U S A; 2016 May; 113(22):6200-5. PubMed ID: 27185936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]